ProShare Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $88.9M | Buy |
|
|||||
|
2025
Q1 | $104M | Buy |
|
|||||
|
2024
Q4 | $104M | Buy |
|
|||||
|
2024
Q3 | $126M | Buy |
|
|||||
|
2024
Q2 | $119M | Sell |
|
|||||
|
2024
Q1 | $121M | Buy |
|
|||||
|
2023
Q4 | $91M | Sell |
|
|||||
|
2023
Q3 | $100M | Buy |
|
|||||
|
2023
Q2 | $78.1M | Sell |
|
|||||
|
2023
Q1 | $94.1M | Buy |
|
|||||
|
2022
Q4 | $75.5M | Sell |
|
|||||
|
2022
Q3 | $82.4M | Sell |
|
|||||
|
2022
Q2 | $84.5M | Sell |
|
|||||
|
2022
Q1 | $145M | Sell |
|
|||||
|
2021
Q4 | $136M | Buy |
|
|||||
|
2021
Q3 | $92.1M | Buy |
|
|||||
|
2021
Q2 | $75.8M | Sell |
|
|||||
|
2021
Q1 | $66.3M | Buy |
|
|||||
|
2020
Q4 | $58.5M | Buy |
|
|||||
|
2020
Q3 | $58.5M | Buy |
|
|||||
|
2020
Q2 | $53.6M | Buy |
|
|||||
|
2020
Q1 | $36.1M | Sell |
|
|||||
|
2019
Q4 | $39.3M | Sell |
|
|||||
|
2019
Q3 | $29.1M | Buy |
|
|||||
|
2019
Q2 | $32M | Sell |
|
|||||
|
2019
Q1 | $42.3M | Sell |
|
|||||
|
2018
Q4 | $39.3M | Buy |
|
|||||
|
2018
Q3 | $37.1M | Sell |
|
|||||
|
2018
Q2 | $37.9M | Sell |
|
|||||
|
2018
Q1 | $40.3M | Buy |
|
|||||
|
2017
Q4 | $43.9M | Buy |
|
|||||
|
2017
Q3 | $44.6M | Buy |
|
|||||
|
2017
Q2 | $43.9M | Buy |
|
|||||
|
2017
Q1 | $33.4M | Sell |
|
|||||
|
2016
Q4 | $36.4M | Buy |
|
|||||
|
2016
Q3 | $37M | Sell |
|
|||||
|
2016
Q2 | $40.7M | Buy |
|
|||||
|
2016
Q1 | $41.5M | Sell |
|
|||||
|
2015
Q4 | $70.4M | Buy |
|
|||||
|
2015
Q3 | $57.1M | Buy |
|
|||||
|
2015
Q2 | $59.8M | Sell |
|
|||||
|
2015
Q1 | $58M | Buy |
|
|||||
|
2014
Q4 | $46.3M | Buy |
|
|||||
|
2014
Q3 | $30.9M | Buy |
|
|||||
|
2014
Q2 | $19.6M | Sell |
|
|||||
|
2014
Q1 | $25M | Buy |
|
|||||
|
2013
Q4 | $21.1M | Buy |
|
|||||
|
2013
Q3 | $16.2M | Buy |
|
|||||
|
2013
Q2 | $10.6M | Buy |
|